TREACE MEDICAL CONCEPTS TMCI 深 沪
已收盘 09-20 16:00:00 美东时间
5.44
-0.160
-2.86%
华盛通- 最 高5.60
- 今 开5.60
- 成交量 85.86万股
- 最 低 5.385
- 昨 收 5.60
- 总市值 3.35亿
- 52周最高 15.98
- 市盈率 静 --
- 换手率 1.40%
- 52周最低 3.92
- 委 比 98.52%
- 总股本 6154.47万
- 历史最高 37.17
- 量 比 1.15
- 振 幅 3.84%
- 历史最低 3.92
- 每 手 1
- 风险率 3.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多快讯 | Treace医疗概念公司: Stifel将目标价从$6上调至$7
Treace Medical Concepts Inc : Stifel Raises Target Price to $7 From $6
08-07 19:34
快讯 | Treace医疗概念公司：Truist Securities将目标价从9美元降至7.5美元。
Treace Medical Concepts Inc : Truist Securities Cuts Target Price to $7.50 From...
08-07 12:57
Treace Medical Concepts Q2 2024 GAAP EPS $(0.34) Misses $(0.29) Estimate, Sales $44.455M Beat $43.000M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.29) by 17.24 percent. This is a 70 percent decrease over losses of $(0.20) per share
08-07 06:00
快讯 | Treace医疗概念公司：重申2024全年营业收入指引
Treace Medical Concepts Inc: Reaffirming Full-Year 2024 Revenue Guidance
08-07 04:29
Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Treace Medical Concepts (NASDAQ:TMCI) has been analyzed by 8 analysts in the la...
07-16 23:01
快讯 | Treace Medical Concepts Inc: 大摩资源lof将目标价从$5.50提高至$8.00。
Treace Medical Concepts Inc : Morgan Stanley Raises Target Price to $8.00 From ...
07-15 21:08
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to b...
05-21 20:39
Unveiling 6 Analyst Insights On Treace Medical Concepts
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quart...
05-17 01:00
UBS downgrades Treace Medical, cites increasing competition
Shares of Treace Medical Concepts (NASDAQ:TMCI) were down 5% in midday trading Thursday amid a downgrade by UBS. In a note dated May 15, UBS said it was lowering its rating on the stock to neutral due...
05-17 00:51
UBS Downgrades Treace Medical Concepts to Neutral, Lowers Price Target to $6.5
UBS analyst Danielle Antalffy downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral and lowers the price target from $16 to $6.5.
05-16 23:05
